Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.

A London-based biotech start-up is accelerating its growth after securing investment to advance artificial intelligence-driven drug discovery technology. Ternary Therapeutics has… | Health | London | ...

In a highly competitive space, AI platforms must now prove themselves through proprietary data, focused pipelines and ...

The collaboration builds on Biophytis' ongoing partnership with LynxKite and aligns with Singapore’s research, innovation and ...

Rentschler taps biopharma vet to lead ops. Rentschler Biopharma, the German CDMO with offices in Massachusetts and Stevenage, ...

Agentic AI could reshape drug development. In this interview, Dr. Claudio D’Ambrosio discusses how agentic AI can identify novel drug compounds, improve trial design, and reduce operational ...

DNA-encoded libraries have numerous advantages over traditional screening methods, including easy identification of compounds and the large quantity of compounds that can be screened simultaneously.

The collaboration targets disease areas where conventional small molecule drug discovery has faced challenges.

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL), ahead of the American Association for Cancer Research® (AACR) Annual Meeting in Chicago, IL, has ...

Explore SLAS Boston 2026 insights on connecting laboratory automation and data infrastructure in drug discovery workflows.